Rituximab in CD20 positive multiple myeloma

被引：0
|
作者：
J M Bergua
C Cabrera
E G Arteta
J Prieto
机构：
[1] Servicio de Hematología,
[2] Hospital San Pedro de Alcántara,undefined
[3] Avda. Pablo Naranjo s/n,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1082 / 1083
页数：1
相关论文
共 50 条
  • [1] Rituximab in CD20 positive multiple myeloma
    P Moreau
    L Voillat
    L Benboukher
    C Mathiot
    C Dumontet
    N Robillard
    O Hérault
    F Garnache
    R Garand
    N Varoqueaux
    H Avet-Loiseau
    J L Harousseau
    R Bataille
    Leukemia, 2007, 21 : 835 - 836
  • [2] Rituximab in CD20 positive multiple myeloma
    Moreau, P.
    Voillat, L.
    Benboukher, L.
    Mathiot, C.
    Dumontet, C.
    Robillard, N.
    Herault, O.
    Garnache, F.
    Garand, R.
    Varoqueaux, N.
    Avet-Loiseau, H.
    Harousseau, J. L.
    Bataille, R.
    LEUKEMIA, 2007, 21 (04) : 835 - +
  • [3] Rituximab in CD20 positive multiple myeloma
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1082 - 1083
  • [4] Reply to rituximab activity in CD20 positive multiple myeloma
    Gozzetti, A.
    Fabbri, A.
    Lazzi, S.
    Bocchia, M.
    Lauria, F.
    LEUKEMIA, 2007, 21 (08) : 1842 - 1843
  • [5] Reply to Rituximab activity in CD20 positive multiple myeloma
    A Gozzetti
    A Fabbri
    S Lazzi
    M Bocchia
    F Lauria
    Leukemia, 2007, 21 : 1842 - 1843
  • [6] Rituximab in CD20 positive multiple myeloma: A prospective study from the IFM group.
    Moreau, Philippe
    Voillat, Laurent
    Benboubker, Lotfi
    Dumontet, Charles
    Mathiot, Claire
    Hulin, Cyrille
    Robillard, Nelly
    Loiseau, Herve Avet
    Herault, Olivier
    Garnache, Francine
    Varoqueaux, Nathalie
    Haroussead, Jean-Luc
    Bataille, Regis
    BLOOD, 2006, 108 (11) : 1021A - 1022A
  • [7] Reply to ‘Rituximab in CD20 positive multiple myeloma’ by P Moreau et al.
    P T Greipp
    P Kapoor
    W G Morice
    T E Witzig
    P R Greipp
    Leukemia, 2008, 22 : 214 - 215
  • [8] Reply to 'Rituximab in CD20 positive multiple myeloma' by P Moreau et al.
    Greipp, P. T.
    Kapoor, P.
    Morice, W. G.
    Witzig, T. E.
    Greipp, P. R.
    LEUKEMIA, 2008, 22 (01) : 214 - 215
  • [9] Reply to 'Rituximab activity in CD20-positive multiple myeloma'
    Bergua, J. M.
    Cabrera, C.
    Arteta, E. G.
    Prieto, J.
    LEUKEMIA, 2008, 22 (05) : 1083 - 1084
  • [10] Reply to ‘Rituximab activity in CD20-positive multiple myeloma’
    A Gozzetti
    A Fabbri
    S Lazzi
    M Bocchia
    F Lauria
    Leukemia, 2008, 22 : 1083 - 1083
12345